FDA recall D-0770-2023

Teva Pharmaceuticals USA Inc · Class III · drug

Product

Fentanyl Buccal Tablets CII, 800mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834, NDC 51862-638-28

Reason for recall

Labeling: Incorrect or Missing Package Insert

Distribution

US Nationwide

Key facts

Status
Terminated
Initiation date
2023-04-27
Report date
2023-05-31
Termination date
2024-02-29
Voluntary/Mandated
Voluntary: Firm initiated
Location
Parsippany, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0770-2023